Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 4
1995 1
1997 1
1999 1
2000 1
2001 2
2002 2
2003 5
2004 1
2005 3
2006 2
2007 1
2010 1
2012 1
2018 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer.
Poole CJ, Perren T, Gawande S, Ridderheim M, Cook J, Jenkins A, Roychowdhury D. Poole CJ, et al. Among authors: ridderheim m. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):507-14. doi: 10.1111/j.1525-1438.2006.00466.x. Int J Gynecol Cancer. 2006. PMID: 16681719 Clinical Trial.
FDG-PET in cervical cancer: staging, re-staging and follow-up.
Bjurberg M, Kjellén E, Ohlsson T, Ridderheim M, Brun E. Bjurberg M, et al. Among authors: ridderheim m. Acta Obstet Gynecol Scand. 2007;86(11):1385-91. doi: 10.1080/00016340701625388. Epub 2007 Sep 4. Acta Obstet Gynecol Scand. 2007. PMID: 17851810 Free article.
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG.
Lindemann K, Christensen RD, Vergote I, Stuart G, Izquierdo MA, Kærn J, Havsteen H, Eisenhauer E, Ridderheim M, Lopez AB, Hirte H, Aavall-Lundquvist E, Vrdoljak E, Green J, Kristensen GB. Lindemann K, et al. Among authors: ridderheim m. Ann Oncol. 2012 Oct;23(10):2613-2619. doi: 10.1093/annonc/mds060. Epub 2012 Apr 26. Ann Oncol. 2012. PMID: 22539562 Free article. Clinical Trial.
28 results